Show Notes
Nature Communications - A FinnGen-based genetic and functional study identifies CFHR5 loss-of-function variants as independently protective against age-related macular degeneration and links reduced FHR-5 to altered complement activity and preserved photoreceptor structure. Key terms: CFHR5, age-related macular degeneration, FinnGen, complement system, FHR-5.
Study Highlights:
A GWAS and fine-mapping in 12,495 AMD cases and 461,686 controls deconvoluted four protective CFH-region haplotypes, two of which are driven by CFHR5 coding variants enriched in Finns. Carriers of a CFHR5 frameshift show dose-dependent loss of circulating FHR-5 and reduced FHR-2 and FHR-4 levels confirmed by SomaScan and Western blot. Functional assays indicate increased classical and alternative complement pathway activation capacity in CFHR5 frameshift homozygotes. UK Biobank retinal OCT analyses show CFHR5 loss-of-function carriers have photoreceptor layer changes consistent with protection from AMD.
Conclusion:
Genetic loss of CFHR5 function reduces FHR-5 levels, modulates complement activation, associates with protective retinal morphology, and identifies FHR-5 downregulation as a promising therapeutic target for AMD.
Music:
Enjoy the music based on this article at the end of the episode.
Article title:
Loss of CFHR5 function reduces the risk for age-related macular degeneration
Journal:
Nature Communications
DOI:
10.1038/s41467-025-61193-3
Reference:
https://doi.org/10.1038/s41467-025-61193-3
License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/
Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00
Official website https://basebybase.com
On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.
Episode link: https://basebybase.com/episodes/cfhr5-loss-reduces-amd-risk
QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-07-31.
QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited the sections describing CFHR5 loss-of-function (fs), dose-dependent FHR-5 reduction and FHR-2/FHR-4 reductions, increased CP/AP complement activation, thicker photoreceptor layers on OCT, recall-by-genotype proteomics, and therapeutic implications; excluded non-scientific intro/outro and unrelated material.
- transcript topics: Overview of age-related macular degeneration (AMD) and forms; CFH/CFHR gene locus and CFHR5 focus; FinnGen cohort, population bottlenecks, and fine-mapping; CFHR5 frameshift variant and dose-dependent protein reductions; Proteomics: SomaScan measurements of FHR proteins; Complement pathways activation (classical, alternative, LP)
QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 5
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0
Metadata Audited:
- article_doi
- article_title
- article_journal
- license
Factual Items Audited:
- CFHR5 frameshift (fs) variant carriers show dose-dependent reductions in FHR-5 serum levels
- CFHR5 fs carriers also exhibit reduced levels of FHR-2 and FHR-4
- CFHR5 fs carriers have higher capacity to activate classical and alternative complement pathways
- CFHR5 fs carriers show thicker/healthier photoreceptor layers on OCT imaging
- Recall-by-genotype study in FinnGen with ~399 participants; AMD protection linked to CFHR5 fs
- CFH haplotypes contribute major AMD risk signals; CFHR5 signals show independent, additive protection
QC result: Pass.
